| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
1997-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7edd87acdea87ec593c8f0a5079b573e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d953a290b74046ddb356ae75aeabbc23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78da34dddc571ec0e4cba8caa122d82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16c30d69dc4f18aa81d3db08701747dd |
| publicationDate |
2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6045795-A |
| titleOfInvention |
Methods and compositions for ameliorating the symptoms of sepsis |
| abstract |
The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CDl4 antibody molecules in a pharmaceutically acceptable excipient is also contemplated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03105898-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003232046-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006206947-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329169-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7148198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005014702-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6974698-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6787522-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7427471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7323448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006276409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6423690-B1 |
| priorityDate |
1989-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |